Registry for patients with lupus at Duke University
Official title: Duke Lupus Registry
Run by Duke University · NCT00512694 · Data updated 2026-11-12
This study is collecting information and blood samples from people with lupus at Duke University to see how the disease changes over time and improve care for patients.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | Duke University Academic / other |
| Locations | 1 site (Durham, North Carolina) |
| Status | Recruiting |
| Started | July 2007 |
| Main results expected | June 2028 |
| Study ends | June 2028 |
| Registry record updated | January 8, 2026 |
| Trial ID | NCT00512694 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients diagnosed with systemic lupus erythematosus or cutaneous lupus who are receiving care from a rheumatologist at Duke University Medical Center.
✕Probably not a fit
Patients who are unable to travel to Duke for follow-up visits or cannot provide informed consent may not benefit from this registry.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The Duke Lupus Registry collects information and blood samples from patients diagnosed with systemic lupus erythematosus or cutaneous lupus who are seen in the Duke Rheumatology clinics. This observational registry aims to track how lupus changes over time, with the goal of improving patient care and informing future research on various lupus-related outcomes. Patients will complete questionnaires and have their disease activity measured during regular clinic visits, without needing additional appointments. The data collected will help enhance treatment strategies and understand the broader implications of lupus.
Why it matters
Potential benefit: If successful, this registry could lead to improved treatment strategies and better management of lupus for patients.
How similar studies have gone: Other observational studies on lupus have shown success in improving patient outcomes and understanding the disease, indicating that this approach is supported by prior research.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of Systemic Lupus Erythematosus or Cutaneous Lupus * Patient of a rheumatologist at Duke University Medical Center Exclusion Criteria: * Inability to travel to Duke for follow-up visits * Inability to speak English * Not able to provide informed consent
Where it's running
-
Duke University Medical Center
Durham, North Carolina, United States Recruiting
Study contacts
- Principal investigator: Megan E. B. Clowse, MD, MPH — Duke University
- Study coordinator: Laura Neil
- Email: laura.k.neil@duke.edu
- Phone: (919) 684-8936
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Registry for pregnant women with autoimmune diseases
This study is trying to learn more about how autoimmune diseases affect pregnant women and their babies to help improve their health during and after pregnancy.
-
Effects of anifrolumab on arterial inflammation in SLE patients
This study tests whether anifrolumab can reduce blood vessel inflammation in people with active systemic lupus erythematosus.
-
Home urine testing for people with lupus
Participants with lupus will try weekly home urine tests in addition to usual care to see if this helps monitor kidney health over a year.
-
CR-402 treatment for refractory autoimmune disease
This study tests CRT-402, a CD19-targeted CAR-T therapy, in adults with active, treatment-resistant autoimmune diseases like SLE, systemic sclerosis, and inflammatory myopathy to see if it is safe and capable of helping control disease.
-
ATG-201 in adults with autoimmune diseases
This early, open-label study tests ATG-201 in adults with autoimmune diseases to see if it is safe and tolerable, and to get initial clues about how the body handles the drug and its effects.
-
Biomarker tests in adults with lupus to see how kidney disease changes over time
Researchers will follow adults with lupus to see if blood and urine biomarkers can predict kidney involvement, flares, and treatment responses during routine care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.